Drug Information Association Logo
Corporate Tagline

3rd Project Management Training Course in Japan

Oct 17 2013 9:30AM - Oct 18 2013 4:45PM | Urban Net Kanda Conference 3-6-2 Uchi Kanda, Chiyoda-ku, Tokyo 101-0047 Japan

« Back to Listing


This is an essential and fundamental Project Management Training Course on pharmaceutical development.

Project Management (PM) was implemented in the pharmaceutical development field in order to manage higher risk in drug development. Project management techniques, definitions and terminologies are not harmonized between pharmaceutical companies yet due to company culture and governance.

However, due to lack of enough organizational PM skill and knowledge, there has been some failure or inefficiency to apply project management system in some organization.

Miscommunication and/or confusion have been observed in co-development programs because each company uses their own PM terminology and concepts. In this training course, the training material of DIA-US PM essential program will be adopted. Participants will be able to learn global standard PM knowledge and techniques and Japan origin which is adoptable in the Global and Local project. All trainers are experienced in pharmaceutical development and certification of PM.

Contact Information 

Online registration has closed.

Keiko Cambridge, Program Manager
Phone +81 3.5575.2130
Fax +81 3.3583.1200


Previous Next

Continuing Education 

The Drug Information Association has been reviewed and approved as a provider of project management training by the Project Management Institute (PMI). This program offers a maximum of 12.75 professional development units (PDUs). PMI#: 2166-000143

The PMI Registered Education Provider logo is a registered mark of the Project Management Institute, Inc.

Name Credit Type Max Credits CEU
3rd Project Management Training Course in Japan PMI 12.75 0.000

Disclosure Policy:

It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Disclosure statements will be included in the course materials.

Statement of Credit:

All participants must sign-in to record attendance for each day of the program. If attendance is not recorded, a participant will not be eligible to receive credit. To request credit, complete the on-line credit request process by logging into DIA’s website at www.diahome.org and sign in at “Login to My DIA” and click on My Transcript. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on November 1, 2013.

Registration Fees 


Member Academia
Member Government
Member Standard


NonMember Academia
NonMember Government
NonMember Standard
Group Discounts

There are no Group Discounts for this event.

CANCELLATION POLICY: On or before October 10, 2013, Administrative fee that will be withheld from refund amount:
Industry (Member or Nonmember) = ¥20,000
Government/Academia/Nonprofit (Member or Nonmember) = ¥10,000

Cancellations must be in writing and be received by the cancellation date above. Registrants who do not cancel by that date and do not attend will be responsible for the full registration fee paid. Registrants are responsible for cancelling their own hotel and airline reservations. You may transfer your registration to a colleague at any time but membership is not transferable. Please notify DIA of any such substitutions as soon as possible. Substitute registrants will be responsible for nonmember fee, if applicable.

DIA reserves the right to alter the venue, if necessary. If an event is cancelled, DIA is not responsible for any airfare, hotel or other costs incurred by registrants.

Register Online
« Back to Listing Back To Top